Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2025
    • The 2024 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Print Subscription
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Video
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe

Endologix Announces Presentation of Favorable Initial PEVAR Trial Results

February 15, 2011 By Bio-Medicine.Org

IRVINE, Calif., Feb. 15, 2011 /PRNewswire/ — Endologix, Inc.
(Nasdaq:
ELGX
), developer of minimally invasive treatments for aortic
disorders, announced today the presentation of the initial clinical
results from the PEVAR Trial at the 2011 iCON (International
Congress of Endovascular Specialists) annual meeting in Scottsdale,
Arizona. Among 33 patients enrolled in the Roll-In phase of the
trial, technical success rates of 97% (access) and 100%
(endovascular repair) have been achieved, with no major adverse
events observed. Patients were discharged from the hospital at an
average of 1.4 days following the procedure.

Participating investigator and presenter Zvonimir Krajcer, MD
(Director, Peripheral Vascular Disease Service, St. Luke’s
Episcopal Hospital at the Texas Heart Institute, Houston, TX)
commented, “In our multidisciplinary practice, a totally
percutaneous approach to endovascular repair with the IntuiTrak
System and Abbott’s Prostar XL closure device has demonstrated
substantial patient benefits as we recently reported in the
Journal of Cardiovascular Surgery.   These initial
outcomes in the PEVAR Trial roll-in phase are consistent with the
published single center data, and have served to support initiation
of the randomized phase of the trial. We are very pleased with the
initial results, and look forward to completion of the randomized
trial very soon.”

The PEVAR Trial is the first multicenter, prospective,
randomized trial of totally percutaneous endovascular repair of
abdominal aortic aneurysm and is being conducted at 20 centers in
the United States under an Investigational Device Exemption
approved by the U.S. Food and Drug Administration.

John McDermott, President and Chief Executive Officer said, “We
applaud the PEVAR Trial investigators for their diligence and
dedication to the trial, and commitment to improving patient
outcomes. We

‘/>”/>

SOURCE

Related Articles Read More >

Verily Study Watch
Verily says its Study Watch could identify heart failure risk
A child using a medical device at home.
Device design takes the spotlight among 2024’s top health tech hazards
These 11 medical device inventions are the best of 2023, Time magazine says
A photo of a Best Buy Geek Squad employee helping a chronic care patient with a remote monitoring device.
Device manufacturers have an unexpected ally for at-home health care
“mdo
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest medical device business news, application and technology trends.

DeviceTalks Weekly

See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to our E-Newsletter
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2025 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2025
    • The 2024 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Print Subscription
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Video
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe